Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VRK1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | ZCCHC11 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | KIF15 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | PLK1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-07 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | MMS22L | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | NUCKS1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | LATS1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | PCGF6 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
mRNA | WDR5 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |